Evaluation of FB-401 in Children, Adolescents and Adults (2 Years and Older) With Mild to Moderate Atopic Dermatitis
Clinical trial NCT04504279 · COMPLETED
Trial details
- NCT number
- NCT04504279
- Sponsor
- Forte Biosciences, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-13
- Primary completion
- 2021-07-14
- Enrollment
- 154
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.